Ribomic Inc.
(株)リボミック
2026/08/21 Updated
Market Cap:
$28.5M (¥4.5B)
Stock Price:
$0.51 (¥81)
Exchange Rate: 1 USD = ¥158.98
Supplementary description on the design and safety of a domestic Phase III clinical trial of achondroplasia treatment drug (umedaptanib pegol)
G-リボミック
Company overview · Stock price · Financial data · All IR